The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...

Scientists may have discovered a way to naturally regulate blood sugar levels and sugar cravings that works similarly to ...

Background: Despite their potential, Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have not been well studied in cardiac amyloidosis (CA) as randomized trials on GLP-1 RA have excluded patients ...

A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like Ozempic and Wegovy, provide significant neurological and behavioral health ...

Speaking to Francesca Rudkin and Louise Ayrey on their NZ Herald podcast, The Little Things, he said many of these medications belong to a group of drugs called glucagon-like peptide-1 (GLP-1 ...

Attribution (BY): Credit must be given to the creator. Lipidated analogues of glucagon-like peptide 1 (GLP-1) have gained enormous attention as long-acting peptide therapeutics for type 2 diabetes and ...

Losing weight on a GLP-1 medication can have emotional and physical effects. Some changes are easier to handle than others, but users say the benefits are worth the effort.

GLP-1 agonists mimic the natural hormone glucagon-like peptide-1 (GLP-1), produced in the small intestine, which regulates key functions: Appetite control: GLP-1 signals your brain to reduce ...

Gain the knowledge and support to find the best solution for your needs. GLP-1 agonists mimic the natural hormone glucagon-like peptide-1 (GLP-1), produced in the small intestine, which regulates key ...

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...